Free Weekly Vaccines Industry Newsletter Get the latest news about Research Breakthroughs, R&D Trends, Clinical Trials, and Vaccine Production sent straight to your Inbox. Join over 25,000 lab research professionals who subscribe to FierceVaccines for FREE!
Novartis ($NVS) has posted positive Phase I data for its H7N9 vaccine, which is now in large-scale production. The trial found two doses of the adjuvanted cell culture vaccine immunologically protected 85% of participants. Release
Innovative Solutions for Biologics Utilizing Advanced Aseptic Processing
| Sponsored by: Catalent
Attendees will gain a fundamental understanding of the advanced aseptic processing utilizing Blow Fill Seal Technology (BFS) and how this innovative technology can be applied to the development and manufacturing of biologics in plastic vials. Reserve Your Spot Today!
FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Click here to get your free weekly email briefing today!